Drug interactions of central nervous system active drugs. 3: Drug interactions of anticonvulsants and antiparkinson agents
Estler, C.J.
Fortschritte der Medizin 102(6): 129-132
1984
ISSN/ISBN: 0015-8178 PMID: 6706270 Document Number: 227851
Document emailed within 1 workday
Related Documents
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168Estler, C.J. 1973: Interactions and incompatibilities of drugs acting upon the central nervous system. 1. Sedatives and hypnotics Fortschritte der Medizin 91(12): 527-530
Moshkova, L.V.; Kumanina, N.P.; Korzhikova, E.B.; Sapegina, L.P. 1990: The information system "Interactions of drugs" and its role in drug therapy Sovetskoe Zdravookhranenie 2: 26-28
Phillips, D.R.; White, R.J.; Trist, H.; Cullinane, C.; Dean, D.; Crothers, D.M. 1990: New insight into drug-DNA interactions at individual drug binding sites probed by RNA polymerase during active transcription of the DNA Anti-Cancer Drug Design 5(1): 21-29
Furue, H. 1986: Application and problems of combination drug therapy--drug interactions of antineoplastic agents and antibiotics Nihon Rinsho. Japanese Journal of Clinical Medicine 44(4): 942-946
Kumar, S.; Rao, P.S.S.; Earla, R.; Kumar, A. 2015: Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems Expert Opinion on Drug Metabolism and Toxicology 11(3): 343-355
Palmer, J.D.; Bressler, R. 1974: Drug--drug interactions. A general discussion about how and where drugs may interact in the body Arizona Medicine 31(2): 89-93
Kigen, G.; Kimaiyo, S.; Nyandiko, W.; Faragher, B.; Sang, E.; Jakait, B.; Owen, A.; Back, D.; Gibbons, S.; Seden, K.; Khoo, S.H.; Nyandiko, W.; Wools-Kaloustian, K.; Kimaiyo, S.; Braitstein, P.; Sang, E.; Jakait, B.; Pastakia, S. 2011: Prevalence of potential drug-drug interactions involving antiretroviral drugs in a large Kenyan cohort Plos one 6(2): E16800
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Hofman, F.M.; Hinton, D.R. 1990: Cytokine interactions in the central nervous system Regional Immunology 3(5): 268-278
Steitz, A.M. 1986: Drugs--drug interactions Connecticut Medicine 50(3): 153-157
Rubinstein, E.; Segev, S. 1987: Drug interactions of ciprofloxacin with other non-antibiotic agents American Journal of Medicine 82(4a): 119-123
Sawada, Y.; Ohtani, H. 2001: Pharmacokinetics and drug interactions of antidepressive agents Nihon Rinsho. Japanese Journal of Clinical Medicine 59(8): 1539-1545
Bressler, R. 2005: Herb-drug interactions: interactions between ginseng and prescription medications Geriatrics 60(8): 16-17
Sawada, Y.; Satoh, H. 2012: Drug interactions of psychotropic drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 70(1): 27-41
Burger, D.M.; Hoetelmans, R.M.; Koopmans, P.P.; Meenhorst, P.L.; Mulder, J.W.; Hekster, Y.A.; Beijnen, J.H. 1997: Clinically relevant drug interactions with antiretroviral agents Antiviral Therapy 2(3): 149-165
Pfeifer, S. 1995: Pharmacokinetic drug interactions. Part 3: Drugs P-Z Die Pharmazie 50(5): 307-332
Haacke, H.; Kolenda, K.D. 1976: Drug interactions in the treatment of primary hyperlipoproteinemias using antilipemic drugs Medizinische Klinik 71(12): 513-517
Prokes, M.; Suchopár, J. 2009: Drug interactions of selected drugs used by patients with diabetes mellitus Vnitrni Lekarstvi 55(4): 395-402
Viramontes-Madrid, J.é L.; Jerjes-Sánchez, C.; Pelaez-Ballestas, I.; Aguilar-Chiu, A.; Hernández-Garduño, A.G. 2002: Risk of drug interactions. Combinations of drugs associated with ventricular arrhythmias Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 54(3): 192-197